The partnership will allow Berg to examine more than 13,000 tissue samples from breast cancer patients for biomarkers that could boost precision medicine and oncology research alike.
The now 17-year-old won a computer science fair at Chicago's Lane Tech College Prep in 2015 for an algorithm that improved on the results of conventional mammography analysis.
True fans of a certain Chicago baseball team are said to bleed Cubbie blue. But Beckham Zobrist wears his loyalty upfront: The 7-year-old Cubs fan's prosthetic eye bears the team logo.
Irvine, Calif.-based Agendia has developed a test the company says makes it easier for physicians to determine if chemotherapy is necessary, sparing many patients from the toxic effects of the drugs, which can leave young women sterile.
Guardant Health, based in Redwood City, Calif., developed a liquid biopsy blood test that has helped match cancer patients with clinical trials and treatment options without costly or invasive biopsies. CEO and co-founder Helmy Eltoukhy calls it a “game changer” for oncology.
Seventeen private health insurance companies and more than 3,200 oncologists working in almost 200 medical groups will participate in the federal government's new cancer care project, but critics argue the program may not easily lower costs or reduce unnecessary and potentially harmful care.
Vice President Joe Biden on Wednesday stressed the importance of research data-sharing and affordability in cancer treatments as goals for his Cancer Moonshot initiative. He also threatened to pull federal funding for cancer studies that fail to publicly disclose their results.
In an emotional speech, Vice President Joe Biden urged the 30,000 oncologists attending the American Society of Clinical Oncology's annual conference to work together in the search for a cure for cancer.
It's well-known that Americans pay more for healthcare and drugs than many other nations, and a recent study confirms that the trend is the same when it comes to oncology drugs.
Some health and civil-rights advocates say guidelines that recommend women postpone breast cancer screenings until they are age 50 should not apply to black women, who are more likely to die if they contract the disease.
As providers are tasked with keeping people healthy through risk-based payment contracts, they're investing in genomics and personalized medicine in order to develop new methods of targeting patients who need early intervention.
Dr. Robert Califf became commissioner of the FDA in February. He brings to the job more than 30 years of experience in clinical trial research at Duke University Medical Center. Califf discusses his priorities and some of the controversies that swirled around his nomination.